• Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases

  • Jul 29 2021
  • Length: 21 mins
  • Podcast

Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases

Listen for free

View show details

  • Summary

  • In this podcast, we invite two authors from recent ARD papers dedicated to the efficacy of mRNA vaccines in patients with immunosuppressive therapies. Christophe Richez, Department of Rheumatology, University Medical Center, Bordeaux, France, and ARD's Social Media Advisor, interviews Bimba Hoyer, Department for Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Germany, and Rebecca H Haberman, Division of Rheumatology, University Grossman School of Medicine, New York, USA. They describe their works and offer their thoughts on the current situation in this area and the future. Related content: https://ard.bmj.com/content/early/2021/05/11/annrheumdis-2021-220272

    https://ard.bmj.com/content/early/2021/06/07/annrheumdis-2021-220597
    Show More Show Less
Show More Show Less

What listeners say about Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available